[Corrigendum] Knockdown of HOXA10 reverses the multidrug resistance of human chronic mylogenous leukemia K562/ADM cells by downregulating P‑gp and MRP‑1.

Int J Mol Med

Department of Biochemistry and Molecular Biology, Key Laboratory of Tumour Molecular Biology, Binzhou Medical University, Yantai, Shandong 264003, P.R. China.

Published: December 2023

Following the publication of the above article, an interested reader drew to the authors' attention that, in Fig. 2 on p. 1408, the microscopic images shown for the light scope images (upper row) and the green fluorescence images (lower row) appeared to be overlapping, such that these images appeared to have been derived from the same original sources even though they were intended to portray the results from differently performed experiments. After having re‑examined their figures, the authors realized that this figure was assembled incorrectly. The revised version of Fig. 2, showing the correct data for all four experimental panels, is shown below. Note that the errors made during the assembly of these figures did not affect the overall conclusions reported in the paper. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of for allowing them the opportunity to publish this. They also apologize to the readership for any inconvenience caused. [International Journal of Molecular Medicine 37: 1405‑1411, 2016; DOI: 10.3892/ijmm.2016.2539].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599347PMC
http://dx.doi.org/10.3892/ijmm.2023.5315DOI Listing

Publication Analysis

Top Keywords

[corrigendum] knockdown
4
knockdown hoxa10
4
hoxa10 reverses
4
reverses multidrug
4
multidrug resistance
4
resistance human
4
human chronic
4
chronic mylogenous
4
mylogenous leukemia
4
leukemia k562/adm
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!